Related Experiment Videos
S100B protein in carbon monoxide poisoning: a pilot study
Miran Brvar1, Hugon Mozina, Josko Osredkar
1Poison Control Center, Ljubljana Medical Center, Zaloska Cesta 7, 1000 Ljubljana, Slovenia.
Resuscitation
|June 3, 2004
Summary
Carbon monoxide (CO) poisoning can cause brain injury. This study found elevated S100B protein levels in patients with CO poisoning, suggesting it may be a useful biomarker for brain damage.
Area of Science:
- Neuroscience
- Toxicology
- Biochemistry
Background:
- Carbon monoxide (CO) poisoning is a leading cause of lethal poisoning worldwide.
- Assessing brain injury in CO poisoning cases can be challenging.
- S100B protein, found in astroglia, is a potential marker for central nervous system damage.
Purpose of the Study:
- To investigate the role of serum S100B as a biochemical marker of brain injury in patients with carbon monoxide poisoning.
- To correlate S100B levels with the severity of CO poisoning and patient outcomes.
Main Methods:
- A prospective clinical study involving 38 consecutive patients admitted to the Emergency Department (ED) for carbon monoxide poisoning.
- Serum S100B levels were determined for all patients.
- Patient outcomes, including consciousness levels and mortality, were recorded.
Main Results:
- Elevated S100B levels were observed in all three patients who were unconscious upon admission.
- The patient with the highest S100B level unfortunately died.
- S100B was elevated in 2 out of 6 patients with transient unconsciousness.
- All 29 patients who did not lose consciousness had normal S100B levels.
Conclusions:
- Carbon monoxide poisoning is associated with elevated serum S100B levels.
- S100B may serve as a valuable biochemical marker for detecting brain injury in carbon monoxide poisoning.
- Further research is warranted to establish S100B's diagnostic and prognostic utility in CO poisoning.